Abstract
BackgroundSocial prescribing aims to connect citizens with sources of support in their communities to benefit their health and well-being. Despite its ongoing implementation within the United Kingdom, the evidence base for social prescribing has been criticised, citing a lack of rigour, high risk of bias and inconclusive findings to date.MethodsThis study protocol aims to examine the feasibility of using large, randomised control studies to assess the mental health and well-being impacts of social prescribing. Two wait-list control studies, each consisting of two parallel arm groups, SPRING and PROPSECT were designed. Participants were referred via their consulting healthcare professionals. The participants were randomised to receive the intervention immediately or after a delay of four weeks. The intervention in the SPRING study was a personal “what-matters” interview by a Link Worker consultation leading to a prescribed social service. Three month and six month follow up of service use was proposed. In PROPSECT, the intervention was a holistic social prescribing service. In both trials the primary outcomes were quality of life, service uptake, and participant experience.DiscussionSocial prescribing is becoming popular in community health and care services. It is believed to be an effective resource, and this is first randomised control trial to attempt to demonstrate the effectiveness of social prescribing for people with Mental Health and/or emotional well-being issues. A waiting-list control study is feasible in this context but would be suitable for larger randomised controlled trials.Trial Registration: SPRING, Clinical Trials, NCT04062903. Registered 17th September 2019, https://clinicaltrials.gov/ct2/show/NCT04062903?term=NCT04062903&draw=2&rank=1. PROSPECT, Clinical Trials, NCT04099095. Registered 23rd September 2019, https://clinicaltrials.gov/ct2/show/NCT04099095?term=NCT04099095&draw=2&rank=1